The big picture is this - the company has NEVER BEEN CASH FLOW POSTIIVE. The stock price is sub penny...even less than half a penny! This company has diluted the stock to hell at the expense of the not so significant share holders. All the good news on this company and stem cells just drives the price down. So, yeah, the big picture looks pretty dismal.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.